This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03484/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03484/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03484/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03484/identifier/drugbank/

Statements

Subject Item
n2:DB03484
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB03484 n11:DB03484
dcterms:title
L-Alpha-Glycerophosphorylethanolamine
adms:identifier
n6:46505577 n7:GPE n8:5459861 n12:DB03484
n3:IUPAC-Name
n4:271B4CAF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4CB5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4CB4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4CB1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4CB2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4CB3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4CAD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4CAE-363D-11E5-9242-09173F13E4C5 n4:271B4CAB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4CAC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4CBB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4CBC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4CB6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4CB7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4CB9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4CB8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4CBA-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4CC1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4CC3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4CC4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4CC0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4CBF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4CC2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4CB0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4CBD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4CBE-363D-11E5-9242-09173F13E4C5